YIL166C Antibody

What is YIL166C/SOA1 and what are the key applications for YIL166C antibodies?

YIL166C, also known as SOA1, is a gene in Saccharomyces cerevisiae (baker's yeast) that has been implicated in telomere maintenance pathways. Research has shown that YIL166C is involved in telomerase-related functions, with expression changes affecting telomere length and Est3p levels in yeast . The gene is located on chromosome IX and its expression has been observed to decrease in synthetic yeast strains at elevated temperatures (37°C) .

YIL166C antibodies are primarily used in research applications including:

• Western blotting (WB) to detect protein expression levels

• Enzyme-linked immunosorbent assay (ELISA) for quantitative protein analysis

• Chromatin immunoprecipitation (ChIP) studies to investigate genomic interactions

These antibodies are valuable tools for examining telomere biology, gene expression changes under stress conditions, and protein-DNA interactions in yeast systems.

What considerations are important when selecting a YIL166C antibody for yeast research?

When selecting a YIL166C antibody for yeast research, several key factors should be considered:

• Antibody specificity: Ensure the antibody specifically recognizes the YIL166C/SOA1 protein from Saccharomyces cerevisiae. Available antibodies have been raised against recombinant Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YIL166C protein .

• Antibody type: Consider whether polyclonal or monoclonal antibodies better suit your research needs. Polyclonal antibodies (like the one described in the search results) recognize multiple epitopes and may provide stronger signals but potentially more background .

• Validated applications: Verify that the antibody has been validated for your specific application. For example, the commercially available YIL166C antibody is validated for ELISA and Western blot applications .

• Species reactivity: Confirm the antibody's species reactivity - available antibodies are specifically reactive with yeast proteins .

• Storage conditions: Adhere to recommended storage conditions (-20°C or -80°C) to maintain antibody integrity and performance over time .

• Additional components: Some antibody products include positive controls (such as recombinant immunogen protein) and pre-immune serum that can be valuable for experimental validation .

What protocols are recommended for using YIL166C antibodies in Western blotting applications?

When using YIL166C antibodies for Western blotting in yeast research, the following optimized protocol is recommended:

Sample preparation:

• Grow yeast cultures to mid-log phase in appropriate media

• Harvest cells by centrifugation (3,000g for 5 minutes)

• Lyse cells using glass bead disruption in buffer containing protease inhibitors

• Clear lysates by centrifugation (14,000g for 10 minutes)

• Determine protein concentration using Bradford or BCA assay

Western blotting procedure:

• Separate 20-50 μg of protein by SDS-PAGE (10-12% gels recommended)

• Transfer proteins to PVDF or nitrocellulose membrane

• Block membrane with 5% non-fat milk in TBST for 1 hour at room temperature

• Incubate with YIL166C primary antibody (1:1000 dilution recommended as starting point)

• Wash 3× with TBST

• Incubate with appropriate secondary antibody (typically anti-rabbit IgG)

• Develop using chemiluminescence or other detection methods

Controls to include:

• Positive control: Use the recombinant immunogen protein provided with some antibody products

• Negative control: Include pre-immune serum to assess non-specific binding

• Loading control: Probe for a housekeeping protein (like ACT1) to normalize expression levels

This protocol can be adapted based on specific research requirements and antibody characteristics.

How can researchers validate the specificity of YIL166C antibodies in their experimental system?

Validating antibody specificity is crucial for generating reliable data. For YIL166C antibodies, the following validation approaches are recommended:

Genetic validation approaches:

• Knockout controls: Compare antibody signal between wild-type and YIL166C deletion strains. Absence of signal in deletion strains confirms specificity .

• Tagged protein controls: Create a FLAG-tagged or other epitope-tagged version of YIL166C and verify co-detection with both tag-specific and YIL166C-specific antibodies .

Biochemical validation approaches:

• Peptide competition assay: Pre-incubate antibody with excess recombinant YIL166C protein (provided with some antibody products) before application to samples. Signal reduction indicates specificity .

• Western blot molecular weight verification: Confirm that the detected band corresponds to the expected molecular weight of YIL166C protein (~40kDa, corresponding to UniProt Number P40445) .

• Immunoprecipitation followed by mass spectrometry: Perform IP with the YIL166C antibody and validate the pulled-down proteins by mass spectrometry to confirm target identity.

Technical controls:

• Use pre-immune serum provided with the antibody as a negative control

• Include positive control recombinant protein provided with some antibody products

• Test antibody performance across multiple applications (e.g., WB, ELISA) to build confidence in specificity

Properly validated antibodies ensure experimental reliability and reproducibility in yeast research systems.

What approaches can detect changes in YIL166C expression under different experimental conditions?

Several approaches can be employed to monitor changes in YIL166C expression under various experimental conditions:

Protein-level expression analysis:

• Western blotting: Use YIL166C antibodies to detect protein levels across different conditions. Normalize to housekeeping proteins like ACT1 .

• ELISA: Quantitatively measure YIL166C protein levels in cellular extracts using validated YIL166C antibodies .

• Immunofluorescence: Examine subcellular localization and relative abundance using fluorescently-labeled secondary antibodies against YIL166C primary antibodies.

Transcriptional analysis:

• RT-qPCR: Measure YIL166C mRNA levels relative to control genes like ACT1 .

• Northern blotting: Analyze YIL166C transcript sizes and abundance.

• RNA-seq: Perform genome-wide expression analysis to place YIL166C expression changes in broader context.

Experimental conditions to consider:

• Temperature stress: Previous research has shown YIL166C expression decreases at 37°C in synthetic yeast strains .

• Growth phase: Monitor expression across logarithmic and stationary phases.

• Carbon source variation: Compare expression in glucose vs. galactose or glycerol media.

• DNA damage conditions: Test expression after hydroxyurea (HU) or other genotoxic treatments .

When analyzing expression data, it's important to perform multiple biological replicates and appropriate statistical analysis to ensure reproducibility of observed changes.

How can YIL166C antibodies be used to investigate telomere maintenance pathways in yeast?

YIL166C has been implicated in telomere maintenance through its relationship with EST3, a crucial yeast telomerase holoenzyme component involved in telomere replication . YIL166C antibodies can be powerful tools for investigating these pathways through several sophisticated approaches:

Chromatin Immunoprecipitation (ChIP) studies:

• ChIP-qPCR: Use YIL166C antibodies to immunoprecipitate protein-DNA complexes and analyze telomeric regions and other potential binding sites using quantitative PCR. This approach can determine whether YIL166C directly associates with telomeric DNA or regulatory regions of telomere-associated genes .

• ChIP-seq: Expand ChIP analysis to genome-wide coverage to identify all genomic binding sites of YIL166C and understand its broader role in chromosomal organization.

Protein-protein interaction analyses:

• Co-immunoprecipitation: Use YIL166C antibodies to pull down protein complexes and identify interacting partners involved in telomere maintenance, such as Est3p and other telomerase components .

• Proximity labeling: Combine YIL166C antibodies with techniques like BioID or APEX to identify proteins in close proximity to YIL166C in living cells.

Functional studies:

• Telomere length analysis: Correlate YIL166C expression levels (detected by antibodies) with telomere length measurements obtained through Southern blotting. Research has shown that modifying regions upstream of EST3 affects both telomere length and Est3p levels, which could be monitored using appropriate antibodies .

• Genetic interaction screens: Use YIL166C antibodies to measure protein levels in various genetic backgrounds to identify genes that affect YIL166C expression or function, potentially uncovering new components of telomere maintenance pathways.

Research has demonstrated that telomere length in yeast strains correlates with Est3p levels, which in turn relates to fitness defects at higher temperatures (37°C) . By employing YIL166C antibodies in conjunction with telomere length analysis, researchers can better understand the relationship between gene expression, protein levels, and phenotypic outcomes in telomere biology.

What approaches can resolve contradictory results when using YIL166C antibodies across different experimental systems?

Researchers occasionally encounter contradictory results when using YIL166C antibodies in different experimental contexts. Several systematic approaches can help resolve these discrepancies:

Antibody validation across systems:

• Cross-validation with multiple antibodies: Use different antibodies targeting distinct epitopes of YIL166C to confirm findings. Consistent results across antibodies increase confidence in observations.

• Epitope mapping: Determine which region of YIL166C the antibody recognizes and consider whether this epitope might be masked in certain experimental conditions or genetic backgrounds.

• Background strain consideration: Yeast strain backgrounds can significantly influence results. Compare antibody performance across strains like S288C, W303, and others commonly used in research .

Technical approach standardization:

• Sample preparation optimization: Systematically compare different lysis methods, buffer compositions, and protein extraction protocols to determine if technical variables contribute to result discrepancies.

• Controls and normalization: Implement stringent control systems including:

  • Positive controls using recombinant YIL166C protein

  • Negative controls using knockout strains and pre-immune serum

  • Loading controls and normalization strategies appropriate for each application

• Antibody titration: Perform detailed antibody dilution series to establish optimal working concentrations for each experimental system.

Genetic approaches to resolve contradictions:

• Tagged constructs: Generate epitope-tagged versions of YIL166C to compare with antibody-detected native protein results .

• Genetic complementation: In studies where genetic modifications affect YIL166C function, perform complementation tests with wild-type and mutant alleles to establish phenotype-genotype relationships, as demonstrated in studies of synthetic chromosome strains .

• Conditional expression systems: Utilize promoter-replacement strategies to control YIL166C expression levels and correlate with antibody detection sensitivity.

Data integration approaches:

• Create a systematic comparison table documenting all experimental variables (strain, temperature, media, experimental approach, antibody source and dilution) alongside observed results to identify patterns explaining contradictions.

• When possible, supplement antibody-based experiments with orthogonal techniques (e.g., mass spectrometry, RNA-seq) to provide independent verification of findings.

How can researchers design ChIP experiments with YIL166C antibodies to investigate chromosomal associations?

Chromatin immunoprecipitation (ChIP) experiments with YIL166C antibodies require careful design to yield reliable insights into chromosomal associations. The following comprehensive approach is recommended:

Experimental design considerations:

• Crosslinking optimization:

  • Test multiple formaldehyde concentrations (0.5-3%) and crosslinking times (5-30 minutes)

  • For certain interactions, consider dual crosslinking with both formaldehyde and a protein-protein crosslinker like DSG or EGS

• Sonication parameters:

  • Optimize sonication conditions to generate DNA fragments of 200-500 bp

  • Verify fragmentation efficiency by gel electrophoresis before proceeding

• Antibody selection and validation:

  • Verify that the YIL166C antibody is suitable for immunoprecipitation

  • Perform preliminary IPs to confirm antibody efficiency in pulling down the target protein

  • Include appropriate controls (IgG, pre-immune serum) in each experiment

Controls and quality checks:

• Input controls: Always reserve 5-10% of chromatin before immunoprecipitation as input control

• Negative controls:

  • IgG control from the same species as the YIL166C antibody

  • Pre-immune serum provided with some antibody products

  • YIL166C deletion strain processed identically to wild-type samples

• Positive controls:

  • Include primers for regions known to be bound by YIL166C or associated factors

  • Consider parallel ChIP for well-characterized chromatin marks or transcription factors

Data analysis and interpretation:

• ChIP-qPCR analysis:

  • Design primers for telomeric regions, potential binding sites, and negative control regions

  • Calculate enrichment as percent of input or relative to IgG control

  • Perform biological replicates (minimum n=3) for statistical validity

• ChIP-seq considerations:

  • Ensure sufficient sequencing depth (minimum 10-20 million reads)

  • Include input controls for normalization during peak calling

  • Utilize appropriate peak-calling algorithms that account for yeast genome characteristics

Specific targets for YIL166C ChIP investigations:

• Telomeric regions: Based on the involvement of YIL166C in telomere maintenance

• tRNA genes: Previous research indicates that tRNA genes and associated sequences upstream of genes like EST3 influence expression, suggesting potential regulatory interactions that could be detected by ChIP

• Genome-wide binding pattern: Analyze binding patterns across chromosomes similar to studies performed for other chromatin-associated factors in yeast

Studies in yeast have shown that deleting specific DNA sequences, including tRNA genes and associated elements, can affect expression of downstream genes like EST3, which influences telomere length . ChIP experiments with YIL166C antibodies could help determine whether there are direct interactions with these genomic regions or if the effects are indirect.

What strategies can overcome common challenges when working with YIL166C antibodies?

Researchers working with YIL166C antibodies may encounter several technical challenges. The following troubleshooting strategies address common issues:

Low signal intensity in Western blots:

• Optimization strategies:

  • Increase antibody concentration incrementally (starting from 1:1000 dilution)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Use more sensitive detection methods (enhanced chemiluminescence or fluorescence-based detection)

  • Increase protein loading (up to 50-75 μg per lane)

  • Optimize transfer conditions for proteins in YIL166C's molecular weight range

• Sample preparation refinements:

  • Use freshly prepared samples to minimize protein degradation

  • Include additional protease inhibitors in lysis buffer

  • Consider non-denaturing conditions if epitope conformation is important

  • Optimize cell lysis method for yeast cells (e.g., glass bead disruption with appropriate buffer)

High background or non-specific binding:

• Blocking optimization:

  • Test different blocking agents (BSA, non-fat milk, commercial blocking solutions)

  • Increase blocking time (2-3 hours at room temperature)

  • Add 0.1-0.3% Tween-20 to washing buffers

• Antibody-specific approaches:

  • Pre-absorb antibody with yeast extracts from YIL166C knockout strains

  • Use the pre-immune serum provided with antibody products to identify non-specific binding

  • Purify antibody using affinity methods if necessary

Inconsistent immunoprecipitation results:

• Buffer optimization:

  • Adjust salt concentration to modify stringency

  • Test different detergents and concentrations

  • Optimize pH conditions for antibody-antigen interaction

• Procedural refinements:

  • Increase antibody amount and incubation time

  • Pre-clear lysates thoroughly to reduce non-specific binding

  • Cross-validate results with epitope-tagged YIL166C versions

Expression level variations across experiments:

• Standardization approaches:

  • Carefully control culture conditions (temperature, media, growth phase)

  • Use internal loading controls consistently (e.g., ACT1)

  • Consider the temperature-dependent expression patterns observed in previous studies

These methodological refinements can significantly improve experimental outcomes when working with YIL166C antibodies in various research applications.

How can researchers interpret YIL166C antibody data in the context of telomere biology studies?

Interpreting YIL166C antibody data in telomere biology studies requires careful consideration of several factors:

Correlating protein levels with telomere phenotypes:

• Establishing baseline relationships:

  • Measure YIL166C protein levels via Western blot across different strain backgrounds

  • Simultaneously assess telomere length using Southern blotting with telomeric probes

  • Create correlation plots between protein abundance and telomere length measurements

• Interpreting threshold effects:

  • Research has demonstrated that telomere maintenance exhibits threshold effects, where extension of telomeres beyond a crucial minimum threshold length suffices to restore fitness

  • When analyzing YIL166C antibody data, consider whether observed changes represent shifts across biologically relevant thresholds rather than simple linear relationships

Contextualizing with related proteins:

• Parallel analysis of telomerase components:

  • Measure levels of Est3p alongside YIL166C, as research has shown relationships between these components

  • Determine whether YIL166C levels correlate with or precede changes in telomerase component abundance

• Regulatory network analysis:

  • Use YIL166C antibodies in conjunction with antibodies against potential upstream regulators

  • Build integrative models of the regulatory relationships between YIL166C and telomere-associated factors

Temperature-dependent considerations:

• Experimental design for temperature studies:

  • When interpreting antibody data across temperature conditions, consider the known temperature-sensitive phenotypes related to YIL166C function

  • Design experiments with appropriate temperature controls and sufficient replication at each condition

  • Account for potential temperature-induced changes in epitope accessibility that might affect antibody binding

• Fitness correlation analysis:

  • Correlate YIL166C levels with growth rates at different temperatures

  • Previous research has shown that strains with telomere-related defects exhibit decreased fitness at 37°C, which correlates with Est3p levels

Data integration framework:

• Multi-level data integration:

  • Create comparative tables documenting:

    • YIL166C protein levels (from antibody experiments)

    • Telomere length measurements

    • Growth rates at different temperatures

    • Expression levels of related genes/proteins

• Genetic background considerations:

  • When comparing data across synthetic and natural yeast strains, account for the genetic modifications that might influence YIL166C function and antibody detection

By systematically analyzing YIL166C antibody data in these contexts, researchers can make more robust interpretations about the protein's role in telomere biology.

How might YIL166C antibodies contribute to understanding chromosome engineering in synthetic biology?

YIL166C antibodies represent valuable tools for advancing our understanding of chromosome engineering in synthetic biology, particularly in projects involving synthetic yeast chromosomes:

Monitoring design-related protein expression changes:

• Synthetic chromosome evaluation:

  • YIL166C antibodies can help monitor protein expression changes resulting from synthetic chromosome designs, similar to studies that identified decreased expression of SOA1 (YIL166C) in synthetic yeast strains at elevated temperatures

  • These antibodies enable researchers to detect unintended consequences of design decisions, such as removal of tRNA genes or repetitive DNA elements that affect nearby gene expression

• Design principle validation:

  • Systematic measurement of YIL166C protein levels across different synthetic chromosome designs can validate or refine design principles

  • Correlation analysis between specific design features (e.g., removal of repetitive elements, tRNA gene relocations) and protein expression can guide future chromosome engineering efforts

Functional analysis of synthetic chromosomes:

• Telomere maintenance in synthetic genomes:

  • YIL166C antibodies can help evaluate how synthetic chromosome designs affect telomere maintenance pathways

  • Given the demonstrated relationship between upstream genetic elements and telomerase component expression, these antibodies provide a means to monitor these interactions in engineered contexts

• Bug identification and resolution:

  • As observed in the synIX project, YIL166C antibodies can assist in identifying and characterizing "bugs" in synthetic chromosome designs that affect fitness

  • By providing quantitative measurements of protein expression, these antibodies enable precise characterization of how design modifications impact cellular function

Methodological contributions to chromosome engineering:

• Quality control metrics:

  • Establish standardized measurement protocols using YIL166C antibodies to assess synthetic chromosome function

  • Develop benchmarking approaches that incorporate protein expression profiles alongside growth and genomic data

• Integration with complementary techniques:

  • Combine YIL166C antibody experiments with chromatin structure analysis techniques like Hi-C or Micro-C to understand how synthetic chromosome designs affect 3D genome organization

  • Integrate with CRISPR-based genome editing to iteratively refine synthetic chromosome designs based on protein expression feedback

Future directions could include developing arrays of antibodies against multiple yeast proteins to create comprehensive expression profiles of synthetic strains, enabling more holistic assessment of synthetic chromosome function and stability.